Results 281 to 290 of about 336,939 (388)
Medications associated with dizziness or hypotension and adverse outcomes: an electronic health record study in older adults with dementia. [PDF]
Sondh HK+5 more
europepmc +1 more source
Evaluation of Anxiety Related to Dizziness or Tinnitus by State-Trait Anxiety Inventory
Makoto Hashimoto+4 more
openalex +2 more sources
Observed and Patient‐Perceived Information Provision When Diagnosed With Parkinson's Disease
Abstract Background People with Parkinson's disease (PD) perceive to receive insufficient disease‐specific information after diagnosis, whereas clinicians report providing all relevant information. Objectives The objectives were to examine the information actually provided by clinicians during diagnostic consultations and its relations with background ...
Elisabeth Kurpershoek+10 more
wiley +1 more source
Prospective quantitative evaluation of gait and stance in patients with acute vertigo and dizziness. [PDF]
Hadzhikolev H+5 more
europepmc +1 more source
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin+8 more
wiley +1 more source
The effect of stepwise acupuncture on cognition, insomnia, and tremors after traumatic brain injury: a case report. [PDF]
Huang TY, Chang CP.
europepmc +1 more source
ABSTRACT Alzheimer's disease (AD) and Parkinson's disease (PD), which are characterized by the accumulation of misfolded protein aggregates and cognitive/motor dysfunction, are the most prevalent neurodegenerative diseases (NDDs). Despite strategic investigations aimed at augmenting the pharmaceutical pipeline, available drugs for AD and PD merely slow
Yoo Joo Jeong+12 more
wiley +1 more source
Assessment of psychological support in patients with unilateral peripheral hypofunction. [PDF]
Lijić L+12 more
europepmc +1 more source
ABSTRACT Introduction/Aims Sevasemten (EDG‐5506) is an orally administered, investigational small molecule that selectively modulates fast muscle fiber contraction by inhibiting fast myosin ATPase. This study assessed the safety, tolerability, and pharmacokinetics (PK)/pharmacodynamics (PD) of sevasemten in healthy adult volunteers (HVs) and adults ...
Joanne Donovan+11 more
wiley +1 more source